Position in GRAL
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$3,586,592
-$2,601,565 QoQ
Shares Held
69,400
-4.0% QoQ
Ownership
0.162%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Swiss National Bank holds $1,778,675,132 across 30 Diagnostics & Research names. GRAL ranks #21 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
1,102,640 | $541,980,639 | |
| 2 | DHR |
Danaher Corp /De/
|
1,865,708 | $353,738,236 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
234,380 | $131,695,778 | |
| 4 | A |
Agilent Technologies, Inc.
|
832,000 | $94,831,360 | |
| 5 | WAT |
Waters Corp /De/
|
288,614 | $85,949,249 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
499,780 | $85,232,481 | |
| 7 | NTRA |
Natera, Inc.
|
385,600 | $77,116,144 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
59,950 | $75,608,940 |
All Filings in GRAL
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,586,592 | 69,400 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $6,188,157 | 72,300 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $3,506,409 | 59,300 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,121,194 | 60,700 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,496,644 | 58,600 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $972,825 | 54,500 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $749,920 | 54,500 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $860,720 | 56,000 | Shares | Sole | 2024-08-08 | |
| No filing history on record for this holder in this stock. | ||||||